1832 Asset Management L.P. Boston Scientific Corp Transaction History

1832 Asset Management L.P.

$48.7 Billion
Q1 2025

A detailed history of 1832 Asset Management L.P. transactions in Boston Scientific Corp stock. As of the latest transaction made, 1832 Asset Management L.P. holds 848,147 shares of BSX stock, worth $87.5 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

848,147

Previous 763,562 11.08%

Holding current value

$87.5 Million

Previous $68.2 Million 25.45%

% of portfolio

0.18%

Previous 0.13%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$89.38 - $106.18 $7.56 Million - $8.98 Million	84,585 Added 11.08%	848,147 $85.6 Million
Q4 2024 Feb 14, 2025	SELL	$83.62 - $91.5 $12.7 Million - $13.9 Million	-152,145 Reduced 16.62%	763,562 $68.2 Million
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $34.9 Million - $40.2 Million	-478,376 Reduced 34.31%	915,707 $76.7 Million
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $64 Million - $73.8 Million	-949,970 Reduced 40.53%	1,394,083 $107 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $12.3 Million - $14.7 Million	-213,986 Reduced 8.37%	2,344,053 $161 Million
Q4 2023 Feb 13, 2024	BUY	$48.64 - $57.81 $24.3 Million - $28.9 Million	499,876 Added 24.29%	2,558,039 $148 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $103 Million - $113 Million	2,058,163 New	2,058,163 $109 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $29.9 Million - $32.9 Million	-601,960 Reduced 23.49%	1,960,933 $106 Million
Q1 2023 May 12, 2023	BUY	$45.09 - $50.03 $38.6 Million - $42.8 Million	855,502 Added 50.11%	2,562,893 $128 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $2,413 - $2,880	-61 Reduced -0.0%	1,707,391 $79 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $496,759 - $1.48 Million	13,532 Added 0.8%	1,707,452 $66.1 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $20.4 Million - $27.3 Million	580,000 Added 52.07%	1,693,920 $63.1 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $7.86 Million - $8.66 Million	192,065 Added 20.83%	1,113,920 $48.7 Million
Q4 2021 Feb 15, 2022	BUY	$38.07 - $44.87 $19.9 Million - $23.4 Million	521,899 Added 130.49%	921,855 $39.9 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.29 Million - $1.44 Million	-31,359 Reduced 7.27%	399,956 $17.7 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $54,860 - $62,909	-1,422 Reduced 0.33%	431,315 $18.6 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $8.75 Million - $9.84 Million	-247,983 Reduced 36.43%	432,737 $16.9 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $10.3 Million - $13.1 Million	312,147 Added 84.69%	680,720 $24.3 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $9.85 Million - $12.1 Million	285,973 Added 346.21%	368,573 $14 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $5.73 Million - $7.43 Million	-189,900 Reduced 69.69%	82,600 $2.89 Million
Q1 2020 May 26, 2020	BUY	$25.83 - $45.71 $7.04 Million - $12.5 Million	272,500 New	272,500 $8.68 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $89.6 Million - $96.6 Million	-2,223,930 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $77.6 Million - $95.6 Million	2,223,930 New	2,223,930 $93.4 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $40.8 Million - $50.6 Million	-1,240,550 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $25.7 Million - $31.6 Million	808,650 Added 187.23%	1,240,550 $43.8 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $14.2 Million - $16.7 Million	431,900 New	431,900 $16.6 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $198,518 - $238,638	-8,008 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $210,290 - $233,593	8,008	8,008 $227,000

Others Institutions Holding BSX

# of Institutions

1,875

Shares Held

1.22B

Call Options Held

9.86M

Put Options Held

7.26M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $148B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account

1832 Asset Management L.P. Boston Scientific Corp Transaction History